Submission Details
| 510(k) Number | K131811 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 19, 2013 |
| Decision Date | July 19, 2013 |
| Days to Decision | 30 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
K131811 is an FDA 510(k) clearance for the UCP COMPACT DRUG TEST CARDS, UCP COMPACT DRUG TEST CUPS, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by Ucp Biosciences, Inc. (San Jose, US). The FDA issued a Cleared decision on July 19, 2013, 30 days after receiving the submission on June 19, 2013. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K131811 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 19, 2013 |
| Decision Date | July 19, 2013 |
| Days to Decision | 30 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |